# Versor Investments LP

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1650301. Source: https://holderbook.com/funds/1650301-versor-investments-lp/

- Reported value: $47.5M
- Positions: 27
- Weight of the ten largest: 55.7%
- Filed: 2026-08-07

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| NUVALENT INC | [NUVL](https://holderbook.com/stocks/NUVL/) | $3.2M | 25,850 | 6.7% | 1 |
| JANUS HENDERSON GROUP PLC | [JHG](https://holderbook.com/stocks/JHG/) | $3.0M | 58,456 | 6.4% | 3 |
| BIO-TECHNE CORP | [TECH](https://holderbook.com/stocks/TECH/) | $3.0M | 42,050 | 6.3% | 1 |
| NORFOLK SOUTHN CORP | [NSC](https://holderbook.com/stocks/NSC/) | $2.7M | 8,532 | 5.6% | 4 |
| SELECT MED HLDGS CORP | [SEM](https://holderbook.com/stocks/SEM/) | $2.7M | 162,328 | 5.6% | 2 |
| TALKSPACE INC | [TALK](https://holderbook.com/stocks/TALK/) | $2.5M | 478,470 | 5.2% | 2 |
| APOGEE THERAPEUTICS INC | [APGE](https://holderbook.com/stocks/APGE/) | $2.4M | 18,222 | 5.1% | 1 |
| CATALYST PHARMACEUTICALS INC | [CPRX](https://holderbook.com/stocks/CPRX/) | $2.4M | 76,286 | 5.0% | 1 |
| UNIFIRST CORP MASS | [UNF](https://holderbook.com/stocks/UNF/) | $2.3M | 8,782 | 4.9% | 2 |
| SILICON LABORATORIES INC | [SLAB](https://holderbook.com/stocks/SLAB/) | $2.3M | 10,530 | 4.8% | 2 |
| ELECTRONIC ARTS INC | [EA](https://holderbook.com/stocks/EA/) | $2.2M | 10,919 | 4.7% | 5 |
| PENUMBRA INC | [PEN](https://holderbook.com/stocks/PEN/) | $2.0M | 6,491 | 4.3% | 2 |
| NCR ATLEOS CORPORATION | [NATL](https://holderbook.com/stocks/NATL/) | $1.9M | 43,921 | 4.0% | 3 |
| QORVO INC | [QRVO](https://holderbook.com/stocks/QRVO/) | $1.9M | 19,836 | 3.9% | 5 |
| STELLAR BANCORP INC | [STEL](https://holderbook.com/stocks/STEL/) | $1.8M | 46,173 | 3.8% | 2 |
| VALARIS LTD | [VAL](https://holderbook.com/stocks/VAL/) | $1.7M | 23,176 | 3.5% | 2 |
| LEGGETT & PLATT INC | [LEG](https://holderbook.com/stocks/LEG/) | $1.6M | 132,455 | 3.3% | 1 |
| AES CORP | [AES](https://holderbook.com/stocks/AES/) | $1.5M | 99,295 | 3.1% | 2 |
| WARNER BROS DISCOVERY INC | [WBD](https://holderbook.com/stocks/WBD/) | $1.3M | 50,068 | 2.8% | 3 |
| ORGANON & CO | [OGN](https://holderbook.com/stocks/OGN/) | $1.2M | 87,640 | 2.5% | 1 |
| DIGITALBRIDGE GROUP INC | [DBRG](https://holderbook.com/stocks/DBRG/) | $879.4K | 55,729 | 1.9% | 3 |
| CHART INDS INC | [GTLS](https://holderbook.com/stocks/GTLS/) | $715.6K | 3,425 | 1.5% | 9 |
| LIVERAMP HLDGS INC | [RAMP](https://holderbook.com/stocks/RAMP/) | $689.9K | 18,328 | 1.5% | 1 |
| ESSENTIAL UTILS INC | [WTRG](https://holderbook.com/stocks/WTRG/) | $603.8K | 15,762 | 1.3% | 3 |
| DOMINION ENERGY INC | [D](https://holderbook.com/stocks/D/) | $501.8K | 7,348 | 1.1% | 1 |
| ARCOSA INC | [ACA](https://holderbook.com/stocks/ACA/) | $358.7K | 2,469 | 0.8% | 1 |
| ROKU INC | [ROKU](https://holderbook.com/stocks/ROKU/) | $216.3K | 1,566 | 0.5% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +3.1% | +14.8% | -11.7% | 64% |
| Q1 2026 | +0.7% | -4.6% | +5.3% | 77% |
| Q4 2025 | +0.6% | +2.4% | -1.8% | 83% |
| Q3 2025 | +4.4% | +7.8% | -3.4% | 92% |
| Q2 2025 | +5.1% | +10.5% | -5.4% | 96% |
| Q1 2025 | -3.9% | -4.6% | +0.7% | 95% |
| Q4 2024 | -0.3% | +2.1% | -2.4% | 96% |
| Q3 2024 | +7.3% | +5.4% | +1.8% | 96% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $47.5M | 27 |
| Q1 2026 | $40.8M | 31 |
| Q4 2025 | $641.8M | 590 |
| Q3 2025 | $543.3M | 606 |
| Q2 2025 | $567.5M | 683 |
| Q1 2025 | $613.4M | 681 |
| Q4 2024 | $580.1M | 725 |
| Q3 2024 | $631.8M | 743 |
| Q2 2024 | $542.3M | 699 |
| Q1 2024 | $494.6M | 661 |
| Q4 2023 | $491.2M | 682 |
| Q3 2023 | $494.4M | 643 |